Cargando…
Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model
PURPOSE: Risk for developing age-related macular degeneration (AMD) is linked to an overactive complement system. In the mouse model of laser-induced choroidal neovascularization (CNV), elevated levels of complement effector molecules, including complement C3, have been identified, and the alternati...
Autores principales: | Parsons, Nathaniel B., Annamalai, Balasubramaniam, Rohrer, Bärbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362922/ https://www.ncbi.nlm.nih.gov/pubmed/37462980 http://dx.doi.org/10.1167/tvst.12.7.17 |
Ejemplares similares
-
Subretinal Rather Than Intravitreal Adeno-Associated Virus–Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage
por: Annamalai, Balasubramaniam, et al.
Publicado: (2021) -
Systemic Inflammation by Collagen-Induced Arthritis Affects the Progression of Age-Related Macular Degeneration Differently in Two Mouse Models of the Disease
por: Schnabolk, Gloriane, et al.
Publicado: (2020) -
The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization
por: Annamalai, Balasubramaniam, et al.
Publicado: (2020) -
Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020) -
Clinical Correlation of Retinal Fluid Fluctuation Represented by Fluctuation Index in Wet Age-Related Macular Degeneration: TOWER Study Report 2
por: Chantarasorn, Yodpong, et al.
Publicado: (2023)